The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohagheghpour, N.
Right arrow Articles by Engleman, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohagheghpour, N.
Right arrow Articles by Engleman, E. G.
The Journal of Immunology, 1998, 161: 2400-2406.
Copyright © 1998 by The American Association of Immunologists

CTL Response to Mycobacterium tuberculosis: Identification of an Immunogenic Epitope in the 19-kDa Lipoprotein1

Nahid Mohagheghpour2,*, Dawn Gammon*, Loyce Masae Kawamura{dagger}, Annika van Vollenhoven{ddagger}, Claudia J. Benike{ddagger} and Edgar G. Engleman{ddagger}

* Kuzell Institute for Arthritis and Infectious Diseases, California Pacific Medical Center Research Institute, San Francisco, CA 94115; {dagger} Division of TB Control, Department of Public Health, San Francisco, CA 94110; and {ddagger} Stanford University Blood Center, Palo Alto, CA 94304

The successful resolution of infection with Mycobacterium tuberculosis (M.tb) is believed to involve the induction of CTLs that are capable of killing cells harboring this pathogen, although little information is known about the MHC restriction or fine specificity of such CTLs. In this study, we used knowledge of the HLA-A*0201-binding motif and an immunofluorescence-based peptide-binding assay to screen for potential HLA-A*0201-binding epitopes contained in the 19-kDa lipoprotein of M.tb (M.tb19). CD8+ T cells derived from HLA-A*0201+ patients with active tuberculosis (TB) as well as tuberculin skin test-positive individuals who had no history of TB were used as effector cells to determine whether these epitopes are recognized by in vivo-primed CTLs. An in vitro vaccination system using HLA-A*0201+ dendritic cells (DCs) as APCs was used to determine whether these epitopes can sensitize naive CD8+ T cells in vitro, leading to the generation of Ag-specific CTLs. The results show that an HLA-A*0201-binding peptide comprised of residues 88 to 97 of M.tb19 (P88–97) is recognized by circulating CD8+ CTLs from both healthy tuberculin skin test-positive individuals and patients with active TB but not by tuberculin skin test-negative subjects. Moreover, dendritic cells pulsed with this peptide induced class I MHC-restricted CTLs from the T cells of healthy unsensitized persons. Finally, CTL lines that were specific for P88–97 were shown to lyse autologous monocytes that had been infected acutely with the H37Ra strain of M.tb. These results demonstrate that M.tb19 elicits HLA class I-restricted CTLs in vitro and in vivo that recognize endogenously processed Ag. Epitopes of the type identified here may prove useful in the design of an M.tb vaccine.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. Aoshi, T. Nagata, M. Suzuki, M. Uchijima, D. Hashimoto, A. Rafiei, T. Suda, K. Chida, and Y. Koide
Identification of an HLA-A*0201-Restricted T-Cell Epitope on the MPT51 Protein, a Major Secreted Protein Derived from Mycobacterium tuberculosis, by MPT51 Overlapping Peptide Screening
Infect. Immun., April 1, 2008; 76(4): 1565 - 1571.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bastian, T. Braun, H. Bruns, M. Rollinghoff, and S. Stenger
Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans
J. Immunol., March 1, 2008; 180(5): 3436 - 3446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Carranza, E. Juarez, M. Torres, J. J. Ellner, E. Sada, and S. K. Schwander
Mycobacterium tuberculosis Growth Control by Lung Macrophages and CD8 Cells from Patient Contacts
Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 238 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Tully, C. Kortsik, H. Hohn, I. Zehbe, W. E. Hitzler, C. Neukirch, K. Freitag, K. Kayser, and M. J. Maeurer
Highly Focused T Cell Responses in Latent Human Pulmonary Mycobacterium tuberculosis Infection
J. Immunol., February 15, 2005; 174(4): 2174 - 2184.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. B. Kamath, J. Woodworth, X. Xiong, C. Taylor, Y. Weng, and S. M. Behar
Cytolytic CD8+ T Cells Recognizing CFP10 Are Recruited to the Lung after Mycobacterium tuberculosis Infection
J. Exp. Med., December 6, 2004; 200(11): 1479 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Aline, D. Bout, S. Amigorena, P. Roingeard, and I. Dimier-Poisson
Toxoplasma gondii Antigen-Pulsed-Dendritic Cell-Derived Exosomes Induce a Protective Immune Response against T. gondii Infection
Infect. Immun., July 1, 2004; 72(7): 4127 - 4137.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Dong, S. Demaria, X. Sun, F. R. Santori, B. M. Jesdale, A. S. De Groot, W. N. Rom, and Y. Bushkin
HLA-A2-Restricted CD8+-Cytotoxic-T-Cell Responses to Novel Epitopes in Mycobacterium tuberculosis Superoxide Dismutase, Alanine Dehydrogenase, and Glutamine Synthetase
Infect. Immun., April 1, 2004; 72(4): 2412 - 2415.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Shams, P. F. Barnes, S. E. Weis, P. Klucar, and B. Wizel
Human CD8+ T cells recognize epitopes of the 28-kDa hemolysin and the 38-kDa antigen of Mycobacterium tuberculosis
J. Leukoc. Biol., December 1, 2003; 74(6): 1008 - 1014.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. A. Lewinsohn, A. S. Heinzel, J. M. Gardner, L. Zhu, M. R. Alderson, and D. M. Lewinsohn
Mycobacterium tuberculosis-specific CD8+ T Cells Preferentially Recognize Heavily Infected Cells
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1346 - 1352.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Nilges, H. Hohn, H. Pilch, C. Neukirch, K. Freitag, P. J. Talbot, and M. J. Maeurer
Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein
J. Virol., May 1, 2003; 77(9): 5464 - 5474.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Kumar, R. R. Amara, V. K. Challu, V. K. Chadda, and V. Satchidanandam
The Apa Protein of Mycobacterium tuberculosis Stimulates Gamma Interferon-Secreting CD4+ and CD8+ T Cells from Purified Protein Derivative-Positive Individuals and Affords Protection in a Guinea Pig Model
Infect. Immun., April 1, 2003; 71(4): 1929 - 1937.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
B. Samten, B. Wizel, H. Shams, S. E. Weis, P. Klucar, S. Wu, R. Vankayalapati, E. K. Thomas, S. Okada, A. M. Krensky, et al.
CD40 Ligand Trimer Enhances the Response of CD8+ T Cells to Mycobacterium tuberculosis
J. Immunol., March 15, 2003; 170(6): 3180 - 3186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Sieling, W. Chung, B. T. Duong, P. J. Godowski, and R. L. Modlin
Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses
J. Immunol., January 1, 2003; 170(1): 194 - 200.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. S. Heinzel, J. E. Grotzke, R. A. Lines, D. A. Lewinsohn, A. L. McNabb, D. N. Streblow, V. M. Braud, H. J. Grieser, J. T. Belisle, and D. M. Lewinsohn
HLA-E-dependent Presentation of Mtb-derived Antigen to Human CD8+ T Cells
J. Exp. Med., December 2, 2002; 196(11): 1473 - 1481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. Lazarevic and J. Flynn
CD8+ T Cells in Tuberculosis
Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1116 - 1121.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Lalvani
CD8 Cytotoxic T Cells and the Development of New Tuberculosis Vaccines
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 789 - 790.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. A. Lewinsohn, R. A. Lines, and D. M. Lewinsohn
Human Dendritic Cells Presenting Adenovirally Expressed Antigen Elicit Mycobacterium tuberculosis-Specific CD8+ T Cells
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 843 - 848.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
Y. Maeda, M. Makino, D. C. Crick, S. Mahapatra, S. Srisungnam, T. Takii, Y. Kashiwabara, and P. J. Brennan
Novel 33-Kilodalton Lipoprotein from Mycobacterium leprae
Infect. Immun., August 1, 2002; 70(8): 4106 - 4111.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. C. Flyer, V. Ramakrishna, C. Miller, H. Myers, M. McDaniel, K. Root, C. Flournoy, V. H. Engelhard, D. H. Canaday, J. A. Marto, et al.
Identification by Mass Spectrometry of CD8+-T-Cell Mycobacterium tuberculosis Epitopes within the Rv0341 Gene Product
Infect. Immun., June 1, 2002; 70(6): 2926 - 2932.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Grode, M. Kursar, J. Fensterle, S. H. E. Kaufmann, and J. Hess
Cell-Mediated Immunity Induced by Recombinant Mycobacterium bovis Bacille Calmette-Guerin Strains Against an Intracellular Bacterial Pathogen: Importance of Antigen Secretion or Membrane-Targeted Antigen Display as Lipoprotein for Vaccine Efficacy
J. Immunol., February 15, 2002; 168(4): 1869 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Panigada, T. Sturniolo, G. Besozzi, M. G. Boccieri, F. Sinigaglia, G. G. Grassi, and F. Grassi
Identification of a Promiscuous T-Cell Epitope in Mycobacterium tuberculosis Mce Proteins
Infect. Immun., January 1, 2002; 70(1): 79 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Pathan, K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. S. Hill, and A. Lalvani
Direct Ex Vivo Analysis of Antigen-Specific IFN-{gamma}-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment
J. Immunol., November 1, 2001; 167(9): 5217 - 5225.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. V. Serbina and J. L. Flynn
CD8+ T Cells Participate in the Memory Immune Response to Mycobacterium tuberculosis
Infect. Immun., July 1, 2001; 69(7): 4320 - 4328.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Chun, N. V. Serbina, D. Nolt, B. Wang, N. M. Chiu, J. L. Flynn, and C.-R. Wang
Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis
J. Exp. Med., May 21, 2001; 193(10): 1213 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. G. Feng, C. Demangel, A. T. Kamath, M. Macdonald, and W. J. Britton
Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8+ T cells with specificity for a novel mycobacterial epitope
Int. Immunol., April 1, 2001; 13(4): 451 - 458.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. A. Post, C. Manca, O. Neyrolles, B. Ryffel, D. B. Young, and G. Kaplan
Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Mycobacterium smegmatis-Induced Cytokine Production by Human Macrophages In Vitro
Infect. Immun., March 1, 2001; 69(3): 1433 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Lewinsohn, L. Zhu, V. J. Madison, D. C. Dillon, S. P. Fling, S. G. Reed, K. H. Grabstein, and M. R. Alderson
Classically Restricted Human CD8+ T Lymphocytes Derived from Mycobacterium tuberculosis-Infected Cells: Definition of Antigenic Specificity
J. Immunol., January 1, 2001; 166(1): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Neyrolles, K. Gould, M.-P. Gares, S. Brett, R. Janssen, P. O'Gaora, J.-L. Herrmann, M.-C. Prevost, E. Perret, J. E. R. Thole, et al.
Lipoprotein Access to MHC Class I Presentation During Infection of Murine Macrophages with Live Mycobacteria
J. Immunol., January 1, 2001; 166(1): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Smith, R. Brookes, M. R. Klein, A. S. Malin, P. T. Lukey, A. S. King, G. S. Ogg, A. V. S. Hill, and H. M. Dockrell
Human CD8+ CTL Specific for the Mycobacterial Major Secreted Antigen 85A
J. Immunol., December 15, 2000; 165(12): 7088 - 7095.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. Smith, M. R. Klein, A. S. Malin, J. Sillah, K. Huygen, P. Andersen, K. P. W. J. McAdam, and H. M. Dockrell
Human CD8+ T Cells Specific for Mycobacterium tuberculosis Secreted Antigens in Tuberculosis Patients and Healthy BCG-Vaccinated Controls in The Gambia
Infect. Immun., December 1, 2000; 68(12): 7144 - 7148.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Geluk, K. E. van Meijgaarden, K. L. M. C. Franken, J. W. Drijfhout, S. D'Souza, A. Necker, K. Huygen, and T. H. M. Ottenhoff
Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans
J. Immunol., December 1, 2000; 165(11): 6463 - 6471.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Mohagheghpour, A. van Vollenhoven, J. Goodman, and L. E. Bermudez
Interaction of Mycobacterium avium with Human Monocyte-Derived Dendritic Cells
Infect. Immun., October 1, 2000; 68(10): 5824 - 5829.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. W. Hodge, A. N. Rad, D. W. Grosenbach, H. Sabzevari, A. G. Yafal, L. Gritz, and J. Schlom
Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules
J Natl Cancer Inst, August 2, 2000; 92(15): 1228 - 1239.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Lewinsohn, A. L. Briden, S. G. Reed, K. H. Grabstein, and M. R. Alderson
Mycobacterium tuberculosis-Reactive CD8+ T Lymphocytes: The Relative Contribution of Classical Versus Nonclassical HLA Restriction
J. Immunol., July 15, 2000; 165(2): 925 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. V. Serbina, C.-C. Liu, C. A. Scanga, and J. L. Flynn
CD8+ CTL from Lungs of Mycobacterium tuberculosis-Infected Mice Express Perforin In Vivo and Lyse Infected Macrophages
J. Immunol., July 1, 2000; 165(1): 353 - 363.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. Smith, A. S. Malin, Pauline T., Lukey, S. E. Atkinson, J. Content, K. Huygen, and H. M. Dockrell
Characterization of Human Mycobacterium bovis Bacille Calmette-Guerin-Reactive CD8+ T Cells
Infect. Immun., October 1, 1999; 67(10): 5223 - 5230.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. G. Feng, A. G. D. Bean, H. Hooi, H. Briscoe, and W. J. Britton
Increase in Gamma Interferon-Secreting CD8+, as Well as CD4+, T Cells in Lungs following Aerosol Infection with Mycobacterium tuberculosis
Infect. Immun., July 1, 1999; 67(7): 3242 - 3247.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Cho, V. Mehra, S. Thoma-Uszynski, S. Stenger, N. Serbina, R. J. Mazzaccaro, J. L. Flynn, P. F. Barnes, S. Southwood, E. Celis, et al.
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis
PNAS, October 24, 2000; 97(22): 12210 - 12215.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.